These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8074443)

  • 1. Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension.
    Zhou XJ; Placidi M; Rahmani R
    Anticancer Res; 1994; 14(3A):1017-22. PubMed ID: 8074443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and metabolism of vinca alkaloids.
    Rahmani R; Zhou XJ
    Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E; Tarasiuk J; Garnier-Suillerot A
    Chem Biol Interact; 1998 Jul; 114(1-2):61-76. PubMed ID: 9744556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
    Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
    Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of two Vinca alkaloids on B16 melanoma in vitro.
    Donoso JA; Himes RH
    Cancer Biochem Biophys; 1984 Jun; 7(2):133-45. PubMed ID: 6467174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Block of axoplasmic transport in vitro by vinca alkaloids.
    Chan SY; Worth R; Ochs S
    J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snail neurons as a possible model for testing neurotoxic side effects of antitumor agents: paracrystal formation by Vinca alkaloids.
    Müller LJ; Moorer-van Delft CM; Roubos EW
    Cancer Res; 1988 Dec; 48(24 Pt 1):7184-8. PubMed ID: 3191492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QM and QM/MD simulations of the Vinca alkaloids docked to tubulin.
    Kelly EB; Tuszynski JA; Klobukowski M
    J Mol Graph Model; 2011 Sep; 30():54-66. PubMed ID: 21798777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
    Howard SM; Theologides A; Sheppard JR
    Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
    Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
    Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of tissue concentrations of vinca alkaloids by radioimmunoassay.
    Owellen RJ; Blair M; Van Tosh A; Hains FC
    Cancer Treat Rep; 1981; 65(5-6):469-75. PubMed ID: 7237468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical and clinical pharmacology of vinca alkaloids.
    Zhou XJ; Rahmani R
    Drugs; 1992; 44 Suppl 4():1-16; discussion 66-9. PubMed ID: 1283846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of vindesine and vincristine in humans.
    Owellen RJ; Root MA; Hains FO
    Cancer Res; 1977 Aug; 37(8 Pt 1):2603-7. PubMed ID: 872088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(6):623-8. PubMed ID: 11985336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
    Ono M; Tanaka N
    In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.
    Krivit W; Anderson J; Chilcote R; Pyesmany A; Chard R; Hammond D
    Am J Pediatr Hematol Oncol; 1980; 2(3):217-21. PubMed ID: 7001942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
    Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
    Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-calmodulin potency of indol alkaloids in in vitro systems.
    Molnár A; Liliom K; Orosz F; Vértessy BG; Ovádi J
    Eur J Pharmacol; 1995 Oct; 291(2):73-82. PubMed ID: 8566178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pharmacokinetics of a new Vinca alkaloid S 12363 with use of a monoclonal antibody-based radio- or enzyme immunoassay.
    Lelievre E; Guillaudeux J; Cardona H; Bourguignat A; Lokiec F; Solere P; Lucas C; Sauveur C
    Cancer Res; 1993 Aug; 53(15):3536-40. PubMed ID: 8339259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.